Leerink Partnrs Has Negative Outlook for JNJ Q3 Earnings
Johnson & Johnson (NYSE:JNJ – Free Report) – Leerink Partnrs dropped their Q3 2025 earnings per share (EPS) estimates for shares of Johnson & Johnson in a research report issued to clients and investors on Wednesday, April 16th. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings of $2.74 per share […]
Johnson & Johnson (NYSE:JNJ – Free Report) – Leerink Partnrs dropped their Q3 2025 earnings per share (EPS) estimates for shares of Johnson & Johnson in a research report issued to clients and investors on Wednesday, April 16th. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings of $2.74 per share […]
